Hifzur R Siddique

Scopus Author ID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 14

Top Venues

Cell death discovery

Drug and chemical toxicology

Epigenomics

Phytotherapy research : PTR

Aligarh Muslim University

CSIR-Indian Institute of Toxicology Research (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Aligarh Muslim University

India

Senior Assistant Professor

Aligarh Muslim University May 12 2017

India

Assistant Professor :: Section of Genetics, Department of Zoology

University of Southern California

United States

Research Associate :: Keck School of Medicine

University of Minnesota Jun 17 2012

United States

Senior Research Associate :: Molecular Chemoprevention and Therapeutics

University of Minnesota Feb 15 2010 - Jun 17 2012

United States

Hormel Fellow :: Molecular Chemoprevention and Therapeutics

University of Wisconsin Madison - Feb 14 2010

United States

Research Associate :: WIMR

Education History

CSIR-Indian Institute of Toxicology Research Jan 28 2003 - Feb 14 2008

India

PHD :: Embryo Toxicology

Aligarh Muslim University

India

MSC :: Section of Genetics, Department of Zoology

Publications

Deepti Singh, Mohammad Afsar Khan, Hifzur R Siddique
Unveiling the therapeutic promise of natural products in alleviating drug-induced liver injury: Present advancements and future prospects. Phytotherapy research : PTR (2023)
Da-Wei Yeh, Xuyao Zhao, Hifzur R Siddique, Mengmei Zheng, Hye Yeon Choi, Tatsuya Machida, Padmini Narayanan, Yi Kou, Vasu Punj, Stanley M Tahara, Douglas E Feldman, Lin Chen, Keigo Machida
MSI2 promotes translation of multiple IRES-containing oncogenes and virus to induce self-renewal of tumor initiating stem-like cells. Cell death discovery 9 (1) (2023)
Da-Wei Yeh, Xuyao Zhao, Hifzur R Siddique, Mengmei Zheng, Hye Yeon Choi, Tatsuya Machida, Padmini Narayanan, Yi Kou, Vasu Punj, Stanley M Tahara, Douglas E Feldman, Lin Chen, Keigo Machida
MSI2 promotes translation of multiple IRES-containing oncogenes and virus to induce self-renewal of tumor initiating stem-like cells. Cell death discovery 9 (1) (2023)
Da-Wei Yeh, Xuyao Zhao, Hifzur R Siddique, Mengmei Zheng, Hye Yeon Choi, Tatsuya Machida, Padmini Narayanan, Yi Kou, Vasu Punj, Stanley M Tahara, Douglas E Feldman, Lin Chen, Keigo Machida
MSI2 promotes translation of multiple IRES-containing oncogenes and virus to induce self-renewal of tumor initiating stem-like cells. Cell death discovery 9 (1) (2023)
Deepti Singh, Mohammad Afsar Khan, Hifzur R Siddique
Role of epigenetic drugs in sensitizing cancers to anticancer therapies: emerging trends and clinical advancements. Epigenomics (2023)
Da-Wei Yeh, Xuyao Zhao, Hifzur R Siddique, Mengmei Zheng, Hye Yeon Choi, Tatsuya Machida, Padmini Narayanan, Yi Kou, Vasu Punj, Stanley M Tahara, Douglas E Feldman, Lin Chen, Keigo Machida
MSI2 promotes translation of multiple IRES-containing oncogenes and virus to induce self-renewal of tumor initiating stem-like cells. Cell death discovery 9 (1) (2023)
Mohd Jameel, Homa Fatma, Liudmila A Nadtochii, Hifzur R Siddique
Molecular Insight into Prostate Cancer: Preventive Role of Selective Bioactive Molecules. Life (Basel, Switzerland) 13 (10) (2023)
Mohammad A Khan, Deepti Singh, Homa Fatma, Kafil Akhtar, Farruk Arjmand, Santosh Maurya, Hifzur R Siddique
Antiandrogen enzalutamide induced genetic, cellular, and hepatic damages: amelioration by triterpene Lupeol. Drug and chemical toxicology (2022)
Santosh Kumar Maurya, Homa Fatma, Akhilesh Kumar Maurya, Nidhi Mishra, Hifzur R Siddique
Role of lupeol in chemosensitizing therapy-resistant prostate cancer cells by targeting MYC, β-catenin and c-FLIP: in silico and in vitro studies. In silico pharmacology 10 (1) (2022)
Deepti Singh, Mohammad Afsar Khan, Kafil Akhtar, Sumbul Rehman, Sabiha Parveen, K M Yusuf Amin, Hifzur R Siddique
Protective effects of a polyherbal medicine, Majoon Suranjan against bisphenol-A induced genetic, oxidative and tissue damages. Drug and chemical toxicology (2022)
Homa Fatma, Hifzur R Siddique, Santosh K Maurya
The multiple faces of NANOG in cancer: a therapeutic target to chemosensitize therapy-resistant cancers. Epigenomics 13 (23) (2021)
Arsheed A Ganaie, Adrian P Mansini, Tabish Hussain, Arpit Rao, Hifzur R Siddique, Ashraf Shabaneh, Marina G Ferrari, Paari Murugan, Jörg Klingelhöfer, Jinhua Wang, Noona Ambartsumian, Christopher A Warlick, Badrinath R Konety, Mohammad Saleem
Anti-S100A4 Antibody Therapy Is Efficient in Treating Aggressive Prostate Cancer and Reversing Immunosuppression: Serum and Biopsy S100A4 as a Clinical Predictor. Molecular cancer therapeutics 19 (12) (2020)
Santosh K Maurya, Akhilesh Kumar Maurya, Nidhi Mishra, Hifzur R Siddique
Virtual screening, ADME/T, and binding free energy analysis of anti-viral, anti-protease, and anti-infectious compounds against NSP10/NSP16 methyltransferase and main protease of SARS CoV-2. Journal of receptor and signal transduction research 40 (6) (2020)
Deepti Singh, Mohammad Afsar Khan, Hifzur R Siddique
Emerging role of long non-coding RNAs in cancer chemoresistance: unravelling the multifaceted role and prospective therapeutic targeting. Molecular biology reports 47 (7) (2020)

Hifzur R Siddique.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Hifzur R Siddique